Skip to main content

Table 3 Standard and modified thromboelastography in all studied patients (pooled data)

From: Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study

  TP1 TP2 TP3 p
Reaction time (mm) 16.7 (13.3–21.6) 17.5 (13.8–21.1) 17.4 (12.9–21.3) 0.84
Coagulation time (mm) 12 (7.3–25.1) 13.7 (7.5–33.2) 15.0 (5.85–33.0) 0.07
Maximal amplitude (mm) 38.5 (26.8–48.8) 35.5 (25.1–50.2) 34.0 (22.7–48.2) 0.0003
Angle alpha (degree) 35 (24.5–51.1) 42 (23.7–54.8) 30.0 (17.8–53.5) 0.002
Clot lysis (percent) 100 (98.7–100) 100 (99.1–100) 100 (98.4–100) 0.68
Coagulation index -0.68 (-6.3–3.9) -1.0 (-6.3–3.6) -1.5 (-7.7–4.6) 0.81
RHEP(mm) 0.7 (-0.5–2.6) 2.9 (0.125–5) 1.4 (0.2–4.1) 0.07
MAPLT (mm) 24 (12.5–31.1) 20 (13.6–28.6) 19 (8.1–29.5) 0.3
  1. MAPLT, difference between standard and abximimab-fab-modified maximal amplitude (MA) reflecting solely the platelet function. RHEP, difference between standard and heparinase modified reaction time (R), reflecting the effects of endogenous/exogenous heparinoids on plasmatic coagulation. TP, time point.